New-generation tyrosine kinase inhibitors (TKIs) for anaplastic lymphoma kinase rearrangement (ALK + ) non-small cell lu...
...ALK)-positive (ALK +) non-small cell lung cancer (NSCLC) in real-world clinical settings remains insufficient. We aim to...
...ALK, and ROS1 mutations has transformed the treatment landscape and improved outcomes for select patient populations. CN...
...ALK and diffusely positive for S100 and SOX10. Fluorescence in-situ hybridization (FISH) revealed EWSR1 rearrangement. N...
...ALK rearrangement on FISH. Despite surgery and 2 courses of 131 I treatments, 18 F-FDG PET/CT showed an intensely avid r...
...ALK)-altered tumors exhibited lower MMP-12 and higher CDH13, whereas Kirsten rat sarcoma viral oncogene homolog (KRAS)-m...
...ALK-therapy and the treatment immediately preceding it. We also assessed real-world radiographic responses on ALK inhibi...
...ALK expression or significant IgG4 infiltration. Concomitant erythema nodosum supported an autoimmune process. Repeat bi...
...ALK RNA) circulating biomarkers. We successfully validated THANOS's excellent biosensing performance in contrived plasma...
...ALK inhibitors, thalidomide, antimetabolites-particularly 5-fluorouracil-and taxanes showed more reproducible signals fo...
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话: 0531-88819269